期刊文献+

原发性肝癌合并骨转移45例临床分析 被引量:7

原文传递
导出
摘要 目的探讨原发性肝癌合并骨转移的诊断方法的综合运用和骨转移综合治疗的疗效及不良反应。方法回顾性分析45例肝癌骨转移的诊治方法及疗效。结果将ECT、MRI、CT多种检查联合应用全部患者骨转移得到确诊。采用经导管动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)、骨转移灶供血动脉灌注及栓塞、双磷酸盐类药物及止痛等综合治疗后,患者疼痛均不同程度缓解,1年生存率55.6%(25/45),2年生存率28.9%(13/45),3年生存率13.3%(6/45),中位生存期13.4个月。结论肝癌合并骨转移采用多种检查手段可以提高诊断阳性率,介入、药物等综合治疗显著改善了患者的生存和生活质量。
出处 《中华全科医学》 2014年第8期1346-1347,共2页 Chinese Journal of General Practice
  • 相关文献

参考文献10

  • 1Jemal A, Bray F, Center MM, et al. Global Cancer statistics [ J ]. CA Cancer J Clin,2011,61 (2) :69-90. 被引量:1
  • 2Ferlay J, Shin HR, Bray F, eta|. Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008 [ J 1. Int J cancer,2010,127 (12) : 2893-2897. 被引量:1
  • 3李照,高杰,孙馨,栗光明,朱继业.肝癌肝移植术后骨转移患者的手术治疗[J].中华普通外科杂志,2013,28(3):193-195. 被引量:3
  • 4何健,曾昭冲,杨平.肝癌肝移植术后骨转移的放射治疗及其对预后的影响[J].实用肿瘤杂志,2012,27(4):332-337. 被引量:2
  • 5刘楠楠,申东兰,陈晓秋,何艳玲.355例恶性肿瘤骨转移的临床分析[J].中华肿瘤杂志,2010,32(3):203-207. 被引量:29
  • 6Luxon BA. Bone disorders in chronic liver diseases [ J ]. Curr Gastroen- terol Rep,2011,12( 1 ) :40-48. 被引量:1
  • 7Malagari K, Pomoni M, Kelekis A, et al. Prospective randomized com- paris on of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma [ J ]. Cardiovasc Intervent Radiol, 2010,33 ( 3 ) : 541-551. 被引量:1
  • 8Raikknen J, Mnkksnen H, Auriola S, et al. Mevalonate pathway in- termediates downregulate zoledronic acid-induced isopentenyl pyro- phosphate and ATP analog formation in human breast cancer cells [ J ]. Biochen Pharmaco1,2010,79 (5) :777-783. 被引量:1
  • 9ChangjW, HsiehJJ, Shen YC, et al. Bisphosphonate zoledronic acid en- hances the inhibitory effects of gefitinib on EGFG-mutated non-small cell lung carcinoma cell [ J ]. Cancer lett,2009,278 ( 1 ) : 17-26. 被引量:1
  • 10Zhang W, Zhu XD, Sun HC, et al. Depletion od Tumor Association Macrophages Enhance the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects [ J ]. Clin Cancer Res ,2010,16 ( 13 ) :3420-3430. 被引量:1

二级参考文献50

共引文献30

同被引文献57

  • 1Shinya Hayashi,Hidekazu Tanaka,Hiroaki Hoshi.Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma[J].World Journal of Hepatology,2014,6(12):923-929. 被引量:8
  • 2肖亚景,苏敏,杨健,刘长江,李鹏.肝癌骨转移的特点及核素骨显像的价值[J].放射学实践,2004,19(9):682-684. 被引量:8
  • 3丰俊东,林代华,刘希琴,戴耀东.刺五加皂苷对人肝癌细胞株血管内皮生长因子表达的抑制作用[J].中药新药与临床药理,2007,18(5):339-341. 被引量:19
  • 4RebeccaL. Boddicker,ElizabethM. Whitley,JeremyE. Davis,DianeF. Birt,MichaelE. Spurlock.Low-Dose Dietary Resveratrol Has Differential Effects on Colorectal Tumorigenesis in Adiponectin Knockout and Wild-Type Mice[J].Nutrition and Cancer.2011(8) 被引量:1
  • 5Chen J G, Zhang S W. Liver cancer epidemic in China: past, present and future [ J ]. Semin Cancer Biol, 2011, 21 ( 1 ) :59-69. 被引量:1
  • 6Jemal A, Bray F, Center M M, et al. Global cancer sta- tistics[J]. CA Cancer J Clin, 2011,61 (2) :69-90. 被引量:1
  • 7Senthilnathan S, Memon K, Lewandowski R J, et al. Ex- trahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients[ J]. Hep- atology, 2012,55 ( 5 ) : 1432-1442. 被引量:1
  • 8Lee H S. Management of patients with hepatocellular car- cinoma and extrahepatic metastasis [ J ]. Dig Dis, 2011,29 (37:333-338. 被引量:1
  • 9中国抗癌协会癌症康复与姑息治疗专业委员会,中国抗癌协会临床肿瘤学协作专业委员会.恶性肿瘤骨转移及骨相关疾病临床诊疗专家共识(2010年版)[M].北京:北京大学医学出版社,2010:3. 被引量:1
  • 10LeungKW, LeungJLY, SyA NL, etal. Bone metas- tasis as the first presentation of hepatocellular carcinoma [J]. J HK Coil Radiol, 2010,12:113-116. 被引量:1

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部